Kidney Injury Molecule -1 (KIM-1): An early novel biomarker for Acute Kidney Injury (AKI) in critically - ill patients

Life Science Journal

Volumn 9, Issue 4, 2012, Pages 3937-3943

  El Naggar, Gamal F ^a   El Srogy, Hesham A ^a   Fathy, Sameh M ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Acute kidney injury (AKI); Critically ill patients; Early biomarker; Kidney injury molecule 1 (KIM 1)

Indexed keywords

EID: 84877011149     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Robert W. Schrier (2004): New biomarkers for acute kidney injury. Schrier; 3: 452-463.
2. Bellomo R, Kellum J, Ronco C (2001): Acute renal failure: time for consensus. Intensive Care Med; 27: 1685-1688.
3. Bellomo R, Ronco C, Kellum JA, et al. (2004): the A DQI workgroup: Acute renal failure-d efinition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference ofthe Acute Dialysis Quality Initiative (ADQI) Group. Crit Care; 8: R204-R212.
4. Bonventre JV (2007): Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol; 156: 213-219.
5. Coca SG, Yalavarthy R, Concato J, et al. (2008): Biomarkers for the diagnosis and risk stratification of acute kidney injury: systematic review. Kidney Int; 73: 1008-1016.
6. Bonventre JV (2007): Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol; 156: 213-219.
7. Ichimura T, Hung CC, Yang SA, et al. (2004): Kidney injury molecule-1: Atissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol; 286: F552-F563
8. Han WK, Alinani A, Wu CL, et al. (2005): Human kidney injury molecule-1 is atissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol; 16: 1126-1134.
9. Waikar SS & Bonventre JV (2007): Biomarkers for the diagnosis of acute kidney injury. Curr Opin Nephrol Hypertens; 16: 557-564.
10. Vaidya VS, Ferguson MA, Bonventre JV (2008): Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol; 48: 463-493.
11. Jones AE, Trzeciak S, Kline JA (2009): The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Critical Care Med; 37(5): 1649-54.
12. Ferreira FL, Bota DP, Bross A, et al. (2001): Serial evaluation of the SOFA scores to predict outcome in critically ill patients. JAM; 286(14): 1754-8.
13. Jones AE, Trzeciak S, Kline JA (2009): The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med.; 37(5): 1649-54.
14. Shalini Chaturvedi, Takeisha Farmer, and Gordon F. Kapke (2009): Assay Validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci; 5(2): 128-134.
15. Levey AS, Bosch JP, Lewis JB, et al. (1999): Amore accurate method to estimate glomerular filtration rate from serum creatinine: anew prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med; 130(6): 461-70.
16. nd edition. By: Blackwell Publishing, Appendix D: 144-152.
17. Star RA (2000): Treatment of acute renal failure. Kidney Int.; 54: 1817-1831.
18. Branten AJ, Mulder TP, Peters WH, et al. (2000): Urinary excretion of glutathione Stransferases alpha and beta in patients with proteinuria, reflection of the site of tubular injury. Nephron; 85: 120-126.
19. Hilton R (2006): Acute renal failure. BMJ; 333(7572): 786-90.
20. Muramatsu Y, Tsujie M, Kohda Y, et al. (2002): Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int; 62: 1601-1610.
21. Oda H, Shiina Y, Seiki K, et al. (2002): Development and evaluation of apractical E LISA for human urinary lipocalin-type prostaglandin Dsynthase. Clin Chem; 48: 1445-1453.
22. Aulitzky WK, Schlegel PN, Wu DF, et al. (1992): Measurement of urinary clusterin as an index of nephrotoxicity. Proc Soc Exp Biol Med; 199: 93-96.
23. Schwartz N, Hosford M, Sandoval RM, et al. (1999): Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar actin alterations. Am J Physiol; 276: F544-551.
24. Westhuyzen J, Endre ZH, Reece G, et al. (2003): Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant; 18: 543-551.
25. Mishra J, Ma Q, Prada A, et al. (2003): Identification of Neutrophil Gelatinase-A ssociated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury. J Am Soc Nephrol; 14: 2534-2543.
26. Ichimura T, Bonventre JV, Bailly V, et al. (1998): Kidney injury molecule-1 (KIM-1), aputative epithelial cell adhesion molecule containing anovel immunoglobulin domain, is upregulated inrenal cells after injury. J Biol Chem; 273: 4135-4142.
27. Han WK, Bailly V, Abichandani R, et al. (2002): Kidney injury molecule-1 (KIM-1): anovel biomarker for human renal proximal tubule injury. Kidney Int.; 62: 237-244.
28. Ichimura T, Hung CC, Yang SA, et al. (2004): Kidney injury molecule-1: atissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol.; 286: F552-F 563.
29. Lin F, Zhang PL, Yang XJ, et al. (2007): Human kidney injury molecule-1 (hKIM-1): auseful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol.; 31: 371-381.
30. Liangos O, Perianayagam MC, Vaidya VS, et al. (2007): Urinary N-acetyl-beta-(D)-g lucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol.; 18: 904-912.
31. Yuzhao Zhou, Vishal S. Vaidya, Ronald P. Brown, etal. (2008): Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium. Toxicol. Sci.; 101 (1): 159-170.
32. FDA News. (2008): FDA, European medicines agency to consider additional test results when assessing new drug safety collaborative effort b y FDA and EMEA expected to yield additional safety data. FDA News 2008; 12 June.
33. Van Timmeren MM, Vaidya VS, Van Ree RM et a l. (2007): High urinary excretion of kidney injury molecule-1 is an independent predictor ofgraft loss in renal transplant recipients. Transplantation; 84: 1625-1630.
34. Ichimura T, Asseldonk EJ, Humphreys BD, et al. (2008): Kidney injury molecule-1 is aphosphatidylserine receptor that confers aphagocytic phenotype on epithelial cells. J Clin Invest; 118: 1657-1668.